Alkem Laboratories AGM 2026: Record Date, ₹10 Dividend

What Alkem Laboratories announced

Alkem Laboratories Ltd has lined up a set of investor-relevant disclosures around its board actions, quarterly results approvals, and the upcoming annual general meeting (AGM). The company has confirmed that its 52nd AGM will be conducted through video conferencing (VC) or other audio-visual means (OAVM), along with remote e-voting for shareholders. Separately, the company has also reported the outcome of a board meeting held on 14 August 2026, where unaudited results for the quarter ended 30 June 2026 were approved.

Board meeting on 14 August 2026: key outcome

In its board meeting held on 14 August 2026, Alkem said the Board approved the standalone and consolidated unaudited financial results for the quarter ended 30 June 2026. The meeting commenced at 11:00 am and concluded at 1:40 pm. The company also noted that the results are available on its website.

52nd AGM date, time, and mode

Alkem Laboratories has scheduled its 52nd Annual General Meeting for Thursday, 27 August 2026 at 11:00 AM IST. The AGM will be held via VC/OAVM. This structure aligns with the company’s AGM notice disclosures included in the shared material, which also reference circulation of the annual report and the audited financial statements for the year ended 31 March 2026.

Voting eligibility and e-voting window

For the 52nd AGM, shareholders holding shares as of the record date, 20 August 2026, are eligible to vote. The company has also provided a remote e-voting facility for members to cast votes on resolutions set out in the AGM notice. Remote e-voting is scheduled to remain open from 24 August to 26 August 2026. Members can vote through remote e-voting or use e-voting during the AGM.

Dividend on the agenda: interim confirmation and final proposal

The AGM agenda includes confirming the payment of interim dividend and declaring the final dividend on equity shares for the financial year ended 31 March 2026. As per the information provided, the Board of Directors, at its meeting held on 28 May 2026, recommended a final dividend of ₹10 per equity share of face value ₹2 each, subject to shareholder approval at the ensuing AGM.

Dividend record date and expected payment date

The company has fixed 7 August 2026 as the record date for determining dividend entitlements for FY25-26, as stated in the shared AGM-related text. If the final dividend is approved by members at the AGM, the company has indicated that the final dividend will be paid on and from Tuesday, 1 September 2026, with other references stating payment on or after 1 September 2026.

Other corporate updates mentioned

The provided material also references that Alkem Laboratories received favourable Orders-in-Appeal from the Commissioner of Income Tax, Appeal – 47, Mumbai for assessment years (AYs) 2018-19 to 2022-23. In addition, in the board meeting outcome cited for 28 May 2026, the company stated that Mrs. Madhurima Singh’s re-appointment as Executive Director for five years from 20 December 2026 was approved.

Stock price snapshot cited in the material

The text includes a market snapshot stating that, as on 10 August 2026 at 03:55 PM IST, Alkem Labs share price was down by 0.39% versus the previous closing price of ₹5,597.5. The share price shown was ₹5,598.50.

Key dates and facts at a glance

Company contact details included

The corporate office address listed is Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai - 400013, Maharashtra, India. The investor email shared is investors@alkem.com, and the website cited is http://www.alkemlabs.com. A telephone number is also listed as +91 22 3982 9999.

Why these disclosures matter for shareholders

The sequence of disclosures brings together near-term corporate actions that typically drive shareholder participation: approval of quarterly financial results, AGM scheduling, voting timelines, and dividend consideration. For investors, the key operational checkpoints are the AGM record date (for voting eligibility), the remote e-voting window, and the dividend payment date contingent on shareholder approval.

Conclusion

Alkem Laboratories has set 27 August 2026 for its 52nd AGM via VC/OAVM, with voting eligibility based on the 20 August 2026 record date and remote e-voting open from 24 to 26 August 2026. The final dividend proposal of ₹10 per equity share for the year ended 31 March 2026 remains subject to shareholder approval, with payment indicated from 1 September 2026 if approved.